# Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise

> **NCT00745264** · PHASE1 · COMPLETED · sponsor: **IDEA AG** · enrollment: 80 (actual)

## Conditions studied

- Pharmacokinetic

## Interventions

- **DRUG:** Diractin
- **DRUG:** Diractin
- **DRUG:** Diractin
- **DRUG:** Diractin

## Key facts

- **NCT ID:** NCT00745264
- **Lead sponsor:** IDEA AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-03
- **Final completion:** 2008-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2009-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00745264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00745264, "Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00745264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*